Arca
Skip to content
Tools
Tools

Reagent Test Strips for Blood

Recall Z-1834-2024, part of FDA recall event 94454. See Macherey-Nagel's company page.

Macherey Nagel Gmbh & Co. Kg started this Class II device recall on Apr 4, 2024 (voluntary: firm initiated); FDA lists it as ongoing.

  • Classification: Class II
  • Started: Apr 4, 2024
  • Status: Ongoing

Why It Was Recalled

Class II

The reason for the recall is one of the test pads, for the parameter leukocytes, was missing on some of the test strips. The issue was identified by a consumer by way of a Henry Schein Inc. (HSI) customer complaint. This problem can potentially result in the possibility that the parameter leucocytes (a non-specific marker for urinary track infections and an indicator for inflammatory renal processes) is interpreted instrumentally as a false negative. The following HSI item number and lot number were affected: Urispec¿ 11-Way, #102-2285, LOT 65402.

Record

Product
Reagent Test Strips for Blood, Urobilinogen, Bilirubin, Protein, Nitrite, Ketones, Ascorbic Acid, Glucose, pH, Specific Gravity and Leucocytes in Urine by the Dip and Read Technique.
Quantity
5,200 packages
Lots and codes
Product #102-2285, UDI/DI: 00304040001479, LOT 65402.
Distribution
US Nationwide distribution in the states of CO, FL, IN, NV, TX.
Recalling firm
Macherey Nagel Gmbh & Co. Kg, Duren, N/A, Germany
How the firm notified
Letter
FDA classified
May 16, 2024

FDA's weekly Enforcement Report, as openFDA publishes it. A recall is classified by how likely the product is to cause harm: Class I is the most serious. openFDA device enforcement reports

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.